metricas
covid
Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) Novel heterogeneity method for predicting survival in non-metastatic triple-nega...
Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Novel heterogeneity method for predicting survival in non-metastatic triple-negative breast cancer
Nuevo método de heterogeneidad para predecir la supervivencia en el cáncer de mama triple negativo no metastásico
G.B. Babacana,f,
Corresponding author
gunduzalp.babacan@saglik.gov.tr

Corresponding author.
, M. Öner Tamama, S. Saraçoğlub, M.N. Acar Tayyara, M.C. Şahina, H. Özçevikc, G. Kuldukd, Ö.B. Ekincie, E. Çelike
a Department of Nuclear Medicine, Prof. Dr. Cemil Taşcıoğlu City Hospital, Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Turkey
b Clinic of Nuclear Medicine, Van Training and Research Hospital, University of Health Sciences, Van, Turkey
c Department of Nuclear Medicine, Başakşehir Çam ve Sakura City Hospital, Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Turkey
d Department of Pathology, Prof. Dr. Cemil Taşcıoğlu City Hospital, Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Turkey
e Department of Medical Oncology, Prof. Dr. Cemil Taşcıoğlu City Hospital, Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Turkey
f Clinic of Nuclear Medicine, Şırrnak State Hospital, Şırnak, Turkey
Read
Not available
Times
was read the article
Total PDF
Total HTML
Share statistics
Article information
ISSN: 22538089
Original language: English
The statistics are updated each day

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos